Pharma's Almanac TV
PA TV
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Follow the Journey
Companies On The Road
Follow The Artist
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2021 Cell & Gene Therapy Report
2021 Monoclonal Antibody & Recombinant Protein Market Report
2021 Sterile Drug Market Report
2021 API Market Report
2020 OSD Market Report
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
More+
Staffing
Media Kit
TriRx Pharmaceutical Services
Articles Available
Can't find what you're looking for? Try our
advanced search
.
Customer Centricity
What to Look for When Choosing the Right CDMO
PAO-09-21-CL-02
New Facility
TriRx Hosted State and Community Leaders to Celebrate Acquisition of Shawnee, Kansas Facility
PR-M07-21-013
Acquisition
TriRx Completes Acquisition of Elanco Animal Health Facility in Shawnee, Kansas
PR-M08-21-01
Quality
The Future of the Delivery of Quality
PAO-07-21-CL-01
Market Research
Survey Launched to Gain Insights into the Evolution of a Changing Pharmaceutical Market
PR-M07-21-02
Facility Acquisition
TriRx Enters Agreement for the Acquisition of Elanco Animal Health Facilities in Shawnee, Kansas and Speke, United Kingdom
PR-M06-21-019
Innovation
The Future of Innovation Post-Pandemic
PTV-04-21-CL-002
Diversification
Product Diversification Through Expansion into the Animal Health Market
PAP-Q4-20-CL-026
The Future of Healthcare
How Does TriRx Envision the Future of the Pharma/Biopharma Industry?
PAP-Q4-20-RT2-004
Cover story
Restarting a Manufacturing Campus and Revitalizing a Community
PAP-Q3-20-CL-016
Integrated CDMO
Building an Integrated and Effective CDMO from the Ground Up
PAP-Q3-20-CL-027
The Future of Healthcare
How Is TriRx Pharmaceutical Services Evolving its Business Model to Meet the Future of Healthcare?
PAP-Q3-20-RT2-006
M&A
TriRx Pharmaceutical Services Acquires MSD Animal Health Manufacturing Site located in Segre-en Anjou Bleu, France Including Long-term Supply Agreement
PR-M09-20-NI-01
COVID-19
Rethinking Pharma’s Responsibilities in a Time of Crisis
PAP-Q2-20-CL-001
The Future of Healthcare
How is TriRx Innovating through the Pandemic and Beyond to Define the Future of Healthcare?
PAP-Q2-20-RT2-005
The Future of Healthcare
How is TriRx Preparing to Face the Future of Healthcare?
PAP-Q1-20-R2-009
CDMO
The Future of the CDMO Market: The Art of the Possible
PAP-Q1-20-CL-035
Capacity Utilization
Solving the Industry’s Capacity Utilization Problem
PAP-Q3-19-CL-033
